Addition Of Januvia (Sitagliptin) Improves Glycemic Control In Patients Inadequately Controlled By Metformin (MK0431-078)

NCT00545584 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1512

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Non-Insulin-Dependent

Interventions

DRUG: sitagliptin phosphate
BEHAVIORAL: Comparator: Diet
BEHAVIORAL: Comparator: Physical Activity

Sponsor

Merck Sharp & Dohme LLC